"checkpoint inhibitor associated pneumonia" trang 4 - tải miễn phí từ tailieuXANH
Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer

Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer
10    41    0
Case report: Reinitiating pembrolizumab treatment after small bowel perforation

Case report: Reinitiating pembrolizumab treatment after small bowel perforation
9    54    0
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial
8    54    0
Intracranial antitumor responses of nivolumab and ipilimumab: A pharmacodynamic and pharmacokinetic perspective, a scoping systematic review

Intracranial antitumor responses of nivolumab and ipilimumab: A pharmacodynamic and pharmacokinetic perspective, a scoping systematic review
8    61    0
A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer

A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer
8    61    0
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system

Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
9    41    0
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy
8    54    0
Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
10    63    0
Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
10    58    0
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
11    89    0
Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: The first report
4    79    0
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review
5    71    0
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report
7    60    0
The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma
11    141    0
AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer

AtezoTRIBE: A randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
9    103    0
Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care
12    116    0
Clinical decision making in the era of immunotherapy for high grade-glioma: Report of four cases

Clinical decision making in the era of immunotherapy for high grade-glioma: Report of four cases
9    53    0
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model

PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
7    55    0
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer
8    60    0
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
11    79    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.